Concepedia

Fengyan Cao

FC

Statistics

Publications

3

Citations

128

H-Index

3

Active since

2017

Affiliations

China Pharmaceutical University(Current)

Fengyan Cao is an author at China Pharmaceutical University specializing in inflammation, medicine, and cell signaling.

Top concepts

Publications per year

2017–2017

3

Publications

3

Mogroside IIIE Attenuates LPS‐Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF‐κB Axis via AMPK Activation

Lijun Tao, Fengyan Cao, Gonghao Xu et al. · Phytotherapy Research · 2017 · 62 citations

, , +23

Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways

Lijun Tao, Jinyu Yang, Fengyan Cao et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 45 citations

Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways

Fengyan Cao, Yunfang Zhang, Weiguang Li et al. · International Immunopharmacology · 2017 · 21 citations

, , +18

1–3 of 3